help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 1, 2007
Endocrinology, doi:10.1210/en.2007-0620
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/2/711    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D.
Right arrow Articles by Murphy, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, D.
Right arrow Articles by Murphy, E.

Submitted on May 10, 2007
Accepted on October 22, 2007

Estrogen Enhanced Gene Expression of Lipoprotein Lipase in Heart is Antagonized by Progesterone

Dianxin Liu, Anne Deschamps, Kenneth S. Korach, and Elizabeth Murphy

Laboratories of, Signal Transduction, and Reproductive and Developmental Toxicology#, NIEHS, NIH, DHHS, Research Triangle Park, NC 27709 and Vascular Medicine Branch, NHLBI, NIH, DHHS, Bethesda, MD 20892

Although estrogen has effects on the heart, little is known regarding which genes in the heart are directly responsive to estrogen. We have shown previously that lipoprotein lipase (LPL) expression was increased in female hearts compared to male hearts. To test whether LPL gene expression in heart is regulated by estrogen, we perfused mouse hearts from ovariectomized females (OVX) with 100nM 17ß-etradiol or vehicle for 2 hours after which hearts were frozen and RNA was isolated. The SYBR green real-time PCR method was used to detect LPL gene expression. We found that addition of 17ß estradiol to hearts from OVX females resulted in a significant increase in LPL mRNA. This estrogen effect on LPL gene expression in mouse heart can be blocked by the estrogen receptor antagonist ICI 182,780 or by progesterone. We also identified a potential estrogen receptor element (ERE) enhancer sequence located in the first intron of the mouse LPL gene. The potential ERE sequence was linked to a TATA-LUC reporter plasmid in HeLa cells. Both estrogen receptor (ER){alpha} and ER{beta} stimulated strong activity on the heterologous promoter reporter in Hela cells upon estrogen addition. Both ER{alpha} and ER{beta} activities on the LPL ERE reporter were abrogated by the estrogen receptor antagonist ICI 182,780. Progesterone also dose dependently inhibited the estrogen mediated increase in LPL ERE reporter activity. These results show that heart LPL is an estrogen responsive gene exhibiting an intronic regulatory sequence.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society